Carlos Alfaras is a Proven Leader in Pharma, Biotech and Healthcare as a C-Suite Executive with a
demonstrated history of success and Skilled Leadership in Pharmaceutical, Biotechnology, Medical Device, Strategic Planning and Business Development.
Expertise includes: Commercialization, Global Branding Strategy & Marketing, Business & Sales Development, Mergers & Acquisitions, Proven Commercial
Growth Strategies in the Healthcare, Biotechnology and generic/Brand Pharmaceutical markets, Healthcare Distribution, Drug Delivery And Product
Inventions, Executive Administration, Personnel Growth and Team Building.
Mr. Alfaras holds patents on Transdermal Drug Delivery and unique Metered
Dose Technology. He attended the University of Miami, majoring in Biology/Pre-Medical studies with a minor in Genetics and utilized this education and
experience to enter the pharmaceutical management world. In his dedication for the pursuit of excellence, he has had successes in creating growth in
revenues and technology footprints at every company he has been associated with through education, team building, strategic planning and efficiently
determining the development strategies for all.
He has held the following positions: Purchasing Director, National Drug Wholesale (Acquired by Harvey
Labs); Director of Purchasing and GM, PHARMED Group; Vice President, Sunshine Medical C.O.O, DNA Pharmaceuticals; Head of Business Development,
Bioniche Pharma (Acquired by Mylan Specialty); Senior Director Alternate Care and Business Development, ANDA Pharmaceuticals/ANDRX
Corporation(Acquired by WATSON Pharmaceuticals); Executive Director, Head of Business Strategy and Global Development ANDA/Watson
Pharmaceuticals (Acquired by TEVA); President & CEO, AHP Group; President & CEO, Gensco Pharma. Board Member of Versea Holdings and
ImmuneBioScience. He is also a member of the following non-profit organizations: Catholic Charities, I9 Sports, Special Olympics International
Carlos Alfaras is dedicated to building a legacy of mentorship both professionally and personally and has been recognized as such by developing an ever-growing
list of successful persons in the industry.